COVID-19
-
April 9, 2020
My daughter had surgery at Children’s Hospital during the COVID-19 changes. Here’s what was different — and what was, thankfully, the same.
Temperature checks and social distancing were very different. The care and concern had not changed at all. -
April 9, 2020
Vanderbilt Health Policy COVID-19 model finds evidence of flattening curve, recommends distancing policies continue
Vanderbilt University Medical Center researchers have found evidence of the rate of COVID-19 infection slowing in Tennessee, which reduces the chance that the state will run out of hospital capacity for patients. -
April 9, 2020
VUMC groups unite to sanitize N95 masks with ultraviolet light
A group of physicians, nurses and representatives from multiple areas throughout VUMC came up with a process in less than a week to safely and effectively sanitize used N95 respirators. -
April 9, 2020
Surveillance key to monitoring exposed employees
Medical surveillance by the Occupational Health Clinic is essential to the COVID-19 response at Vanderbilt University Medical Center. -
April 8, 2020
Self-care crucial for providers during pandemic
High levels of stress and anxiety can be debilitating, especially for health care providers on the front lines of the COVID-19 pandemic. But there are ways they can protect themselves and their ability to provide the best and most compassionate care. -
April 8, 2020
VUMC explores strategy to protect Emergency Department providers during COVID-19 pandemic
Policy changes related to telemedicine that were quickly implemented during the novel coronavirus pandemic (COVID-19) have created opportunities for technology-based clinical evaluation, which serves to protect patients and providers alike, while conserving personal protective equipment (PPE). -
April 8, 2020
Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments
Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.